- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03600272
Comparison of Combined Spinal-epidural Analgesia Versus Epidural Analgesia for Pain Management During Labor
July 25, 2018 updated by: Deng Dongrui
Comparison of Combined Spinal-epidural Analgesia Versus Epidural Analgesia During Labor
The investigators want to compare the safety and efficacy between the combined spinal-epidural analgesia and epidural analgesia during labor.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Participants who request neuraxial labor analgesia are randomized to receive combined spinal-epidural analgesia or epidural analgesia during labor.
The investigators collect the data on the duration of three stages of labor, the mode of delivery, neonatal Apgar scores, VAS scores, modified Bromage scores.
Study Type
Interventional
Enrollment (Anticipated)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Hubei
-
Wuhan, Hubei, China, 430030
- Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
15 years to 50 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Healthy women at term (37 to 42 weeks of gestation), vertex presentation, singleton pregnancy who desired vaginal delivery were eligible to participate.
Exclusion Criteria:
- Contraindications to neuraxial techniques such as clinically significant coagulopathy and increased intracranial pressure, and patients with preterm labor, multiple pregnancies, non-vertex presentation, cephalopelvic disproportion and severe obstetric complications
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Combined spinal-epidural analgesia
The combined spinal epidural analgesia technique was used to maintain analgesia for parturients in the combined spinal-epidural analgesia group.
First, the investigator injected a dose of 5 ug sufentanil into cerebrospinal fluid.
If no adverse effects were observed 10 minutes after the first dose, the parturient then received mixed liquids of 0.075% ropivacaine and 0.2ug/ml sufentanil citrate through a patient-controlled epidural analgesia (PCA) pump, which provided patients themixed solution at 8-10ml/h to optimize their pain relief until the delivery of neonates.
|
Combined spinal-epidural analgesia during labor is a labor analgesia technique which reported maybe associate with a shorter labor duration compared to the traditional epidural labor analgesia.
|
|
Other: Epidural analgesia
The epidural analgesia technique was used to maintain analgesia for parturients in the epidural analgesia group, which involved placing a thin catheter through a needle inserted into the epidural space.
First, the investigator injected a test dose of 5ml 1% lidocaine through it.
If not adverse effects were observed 10 minutes after the test dose, the parturient then received a bolus injection of an initial dose of 8-10 ml mixed liquids of 0.075% ropivacaine and 0.2ug/ml sufentanil citrate.
We then connected the catheter with a patient-controlled epidural analgesia (PCA) pump, which provided patients the same mixed solution at 8-10ml/h to optimize their pain relief until the delivery of neonates.
|
Epidural analgesia is a well-accepted technique using for pain relief during labor.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Labor duration
Time Frame: At the end of delivery
|
Duration of three stages of labor
|
At the end of delivery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The mode of delivery
Time Frame: At the end of delivery
|
Including spontaneous vaginal delivery, vacuum- and forceps-assisted delivery, cesarean delivery
|
At the end of delivery
|
|
1 minute and 5 minutes Apgar scores
Time Frame: 1 min after delivery, 5 min after delivery.
|
Neonatal Apgar scores at the first and fifth minute.The score indicates the infant s' conditions, including heart rate, breathing, muscle tone, reflex response, color.
Each characteristic is given an individual score; two points for each of the five categories if all is completely well; then all scores are totaled.
The score is from 0 to 10.
|
1 min after delivery, 5 min after delivery.
|
|
Visual Analogue Scores(VAS)
Time Frame: At 5min before analgesia; at 5min, 15min, 30min, 1h after the first dose of analgesic drugs; at cervical dilation of 3cm , 6cm and 10cm; at the time of birth of infant; at the time of delivery of placenta.
|
VAS is the most common pain scale for quantification.
The score is higher, the patient will be more painful.
That will indicate if the analgesia is effective.
Visual analog scale (VAS) ranging from 0 to 10 (with 10 representing the worst pain imaginable) to measure the degree of pain for participants.
|
At 5min before analgesia; at 5min, 15min, 30min, 1h after the first dose of analgesic drugs; at cervical dilation of 3cm , 6cm and 10cm; at the time of birth of infant; at the time of delivery of placenta.
|
|
Modified Bromage scores
Time Frame: At 5min before analgesia; at 5min, 15min, 30min, 1h after the first dose of analgesic drugs; at the cervical dilation of 3cm , 6cm and 10cm; at the time of birth of infant; at the time of delivery of placenta.
|
The modified Bromage score is the most frequently used measure of motor block.
In this scale, the intensity of motor block is assessed by the patient's ability to move their lower extremities(0: no motor paralysis; 1: inability to raise extended leg, but able to move knee and foot; 2: inability to raise extended leg and to move knee, but able to move foot; 3: inability to raise extended leg or to move knee and foot).
|
At 5min before analgesia; at 5min, 15min, 30min, 1h after the first dose of analgesic drugs; at the cervical dilation of 3cm , 6cm and 10cm; at the time of birth of infant; at the time of delivery of placenta.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Haiyi Liu, M.D., Tongji Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
July 20, 2018
Primary Completion (Anticipated)
November 20, 2018
Study Completion (Anticipated)
July 20, 2019
Study Registration Dates
First Submitted
July 10, 2018
First Submitted That Met QC Criteria
July 24, 2018
First Posted (Actual)
July 26, 2018
Study Record Updates
Last Update Posted (Actual)
July 27, 2018
Last Update Submitted That Met QC Criteria
July 25, 2018
Last Verified
July 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TJ-C20180711
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Labor Pain
-
Antalya Bilim UniversityCompletedChildbirth | Normal Labor | Labor Pain and to Reduce PainTurkey (Türkiye)
-
Pınar ErdoğanCompletedLabor Progress | Labor Pain and AnxietyTurkey (Türkiye)
-
Soovu Labs Inc.Virginia Mason Hospital/Medical CenterNot yet recruiting
-
Bogomolets National Medical UniversityCompleted
-
Cairo UniversityNot yet recruiting
-
Martin-Luther-Universität Halle-WittenbergCompleted
-
Maimonides Medical CenterTerminated
-
Roi TreisterHillel Yaffe Medical CenterNot yet recruitingLabor Pain and to Reduce PainIsrael
-
Aretaieio HospitalRecruitingLabor Pain | Pain, Labor | EpiduralGreece
Clinical Trials on Combined spinal-epidural analgesia
-
ShanWu Feng, M.D.UnknownPain | Neurologic Manifestations | Labor Pain | Signs and Symptoms | Pathological Conditions, Signs and SymptomsChina
-
Bursa City HospitalRecruitingPostoperative Pain After Cesarean SectionTurkey (Türkiye)
-
St. Justine's HospitalNot yet recruitingSatisfaction, Patient | Urinary Retention | Pruritis | Labor Analgesia | Hypotension Drug-Induced | Opioid Analgesic Adverse Reaction | Fentanyl Adverse Reaction | Term Labour | Fetal Bradycardia During Labor | Fentanyl Analgesia | Neuraxial Opioid | Nausea and VomittingCanada
-
University of PadovaRecruitingLabor Analgesia | Expectations | Postpartum Depression (PPD)Italy
-
Prince Sattam Bin Abdulaziz UniversityCompletedPain, Postoperative | Labor Pain | Pain, AcuteSaudi Arabia
-
Wake Forest University Health SciencesCompleted
-
Mayo ClinicUniversity of British ColumbiaEnrolling by invitationAnalgesia | AnesthesiaUnited States, Canada
-
Helsinki University Central HospitalCompleted
-
Diskapi Teaching and Research HospitalCompletedKnee Arthropathy | Hip Arthropathy | Anesthesia; Adverse Effect, Spinal and EpiduralTurkey
-
Sakarya UniversityCompletedUltrasonography | Combined Spinal Epidural Anesthesia | Obesity (Body Mass Index >30 kg/m2)Turkey (Türkiye)